Tracy L. McGaha

Tracy L. McGaha

Auto-generated profile, based on publicly available information

Tracy L. McGaha

Preprint Club, University of Oxford, Oxford, UK

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2022 in Immunity
Verified
Journal Article
Closed access
KHKebria Hezaveh
Kebria Hezaveh
RSRahul S. Shinde
Rahul S. Shinde
AKAndreas Klötgen
Andreas Klötgen
MHMarie Jo Halaby
Marie Jo Halaby
SLSara Lamorte
Sara Lamorte
TMTracy L. McGaha
Tracy L. McGaha

1 August 2017 in Trends in Immunology
Verified
Journal Article
Closed access
LSLaura M. Snell
Laura M. Snell
TMTracy L. McGaha
Tracy L. McGaha
DBDavid Brooks
David Brooks

1 March 2008 in Blood
Verified
Journal Article
Open access
EBElodie Belnoue
Elodie Belnoue
MPMaria Pihlgren
Maria Pihlgren
TMTracy L. McGaha
Tracy L. McGaha
CTChantal Tougne
Chantal Tougne
ARAnne-Françoise Rochat
Anne-Françoise Rochat
CSClaire-Anne Siegrist
Claire-Anne Siegrist
The persistence of serum IgG antibodies elicited in human infants is much shorter than when such responses are elicited later in life. The reasons for this rapid waning of antigen-specific antibodies elicited in infancy are yet unknown. We have recently shown that adoptively transferred tetanus toxoid (TT)–specific plasmablasts (PBs) efficiently reach the bone marrow (BM) of infant mice. However, TT-specific PBs fail to persist in the early-life BM, suggesting that they fail to receive the molecular signals that support their survival/differentiation. Using a proliferation-inducing ligand (APRIL)– and B-cell activating factor (BAFF) B-lymphocyte stimulator (BLyS)–deficient mice, we demonstrate here that APRIL is a critical factor for the establishment of the adult BM reservoir of anti-TT IgG-secreting cells. Through in vitro analyses of PB/plasma cell (PC) survival/differentiation, we show that APRIL induces the expression of Bcl-XL by a preferential binding to heparan sulfate proteoglycans at the surface of CD138+ cells. Last, we identify BM-resident macrophages as the main cells that provide survival signals to PBs and show that this function is slowly acquired in early life, in parallel to a progressive acquisition of APRIL expression. Altogether, this identifies APRIL as a critical signal for PB survival that is poorly expressed in the early-life BM compartment.

1 December 2018 in Trends in Immunology
Verified
Journal Article
Closed access
RSRahul Shinde
Rahul Shinde
TMTracy L. McGaha
Tracy L. McGaha

21 February 2006 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
MEMarc Ehlers
Marc Ehlers
HFHidehiro Fukuyama
Hidehiro Fukuyama
TMTracy L. McGaha
Tracy L. McGaha
AAAlan Aderem
Alan Aderem
JRJeffrey V. Ravetch
Jeffrey V. Ravetch
Loss of tolerance in systemic lupus erythematosus (SLE) leads to the generation of autoantibodies, which accumulate in end-organs where they induce disease. Here we show that immunoglobulin (Ig)G2a and 2b autoantibodies are the pathogenic isotypes by recruiting FcγRIV expressing macrophages. Class switching, but not development, of IgM anti-self B cells to these pathogenic subclasses requires the innate immune receptor Toll-like receptor (TLR)9 and MyD88 signaling. In their absence, switching of autoreactive B cells to the IgG2a and 2b subclasses is blocked, resulting in reduced pathology and mortality. In contrast, switching of anti-self B cells to IgG1 is not perturbed and generation of nonautoreactive IgG2a and 2b antibodies is not impaired in TLR9-deficient mice. Thus, the TLR9 pathway is a potential target for therapeutic intervention in SLE.

28 January 2005 in Science
Verified
Journal Article
Closed access
PDF file
TMTracy L. McGaha
Tracy L. McGaha
BSBrian Sorrentino
Brian Sorrentino
JRJeffrey V. Ravetch
Jeffrey V. Ravetch
Lupus, a multigenic autoimmune condition in which a breakdown of tolerance results in the development of autoantibodies, leads to a variety of pathologic outcomes. Despite the heterogeneity of factors influencing disease susceptibility, we demonstrate that the partial restoration of inhibitory Fc receptor (FcgRIIB) levels on B cells in lupus-prone mouse strains is sufficient to restore tolerance and prevent autoimmunity. FcgRIIB regulates a common B cell checkpoint in genetically diverse lupus-prone mouse strains, and modest changes in its expression can result in either tolerance or autoimmunity. Therefore, increasing FcγRIIB levels on B cells may be an effective way to treat autoimmune diseases.